Page last updated: 2024-10-28

hydroxyurea and Osteonecrosis

hydroxyurea has been researched along with Osteonecrosis in 8 studies

Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Research Excerpts

ExcerptRelevanceReference
" Pregnancy is a high-risk situation for the mother and child The efficacy and safety of hydroxyurea and long-term blood transfusions in adults with sickle cell disease are currently under investigation."4.84[New issues in adult sickle sell disease]. ( Girot, R; Lionnet, F; Stankovic, K, 2008)
" Most lesions were osteonecrosis and osteoarthritis and were statistically associated with the non-use of hydroxyurea."4.02Chronic osteo-articular changes in patients with sickle cell disease. ( de Araújo Pereira, G; Dos Santos, APT; Ferreira, TFA; Leal, AS; Moraes-Souza, H; Silva, SS, 2021)
"Sickle beta+thalassemia is considered to be a mild form of sickle cell disease."1.72Multifocal Osteonecrosis in a 3-Year-old Child With Sickle Beta Plus Thalassemia. ( Bhasin, N; Desoky, SM; Price, N, 2022)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Adesina, OO1
Neumayr, LD1
Ferreira, TFA1
Dos Santos, APT1
Leal, AS1
de Araújo Pereira, G1
Silva, SS1
Moraes-Souza, H1
Bhasin, N1
Price, N1
Desoky, SM1
Lemonne, N1
Lamarre, Y1
Romana, M1
Mukisi-Mukaza, M1
Hardy-Dessources, MD1
Tarer, V1
Mougenel, D1
Waltz, X1
Tressières, B1
Lalanne-Mistrih, ML1
Etienne-Julan, M1
Connes, P1
Belini Junior, E1
Silva, DG1
Torres, Lde S1
Okumura, JV1
Lobo, CL1
Bonini-Domingos, CR1
Sidani, CA1
Ballourah, W1
El Dassouki, M1
Muwakkit, S1
Dabbous, I1
Dahoui, H1
Al-Kutoubi, A1
Abboud, MR1
Girot, R1
Stankovic, K1
Lionnet, F1
Novelli, EM1
Kato, GJ1
Ragni, MV1
Zhang, Y1
Hildesheim, ME1
Nouraie, M1
Barge, S1
Meyer, MP1
Hassett, AC1
Gordeuk, VR1
Gladwin, MT1
Isenberg, JS1

Reviews

2 reviews available for hydroxyurea and Osteonecrosis

ArticleYear
Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.
    Hematology. American Society of Hematology. Education Program, 2019, 12-06, Volume: 2019, Issue:1

    Topics: Adolescent; Anemia, Sickle Cell; Child; Female; Humans; Hydroxyurea; Middle Aged; Osteonecrosis; Pre

2019
[New issues in adult sickle sell disease].
    Bulletin de l'Academie nationale de medecine, 2008, Volume: 192, Issue:7

    Topics: Adult; Anemia, Sickle Cell; Blood Transfusion; Cardiomyopathies; Combined Modality Therapy; Female;

2008

Other Studies

6 other studies available for hydroxyurea and Osteonecrosis

ArticleYear
Chronic osteo-articular changes in patients with sickle cell disease.
    Advances in rheumatology (London, England), 2021, 02-19, Volume: 61, Issue:1

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Cross-Sectional Studies; Female; Hemogl

2021
Multifocal Osteonecrosis in a 3-Year-old Child With Sickle Beta Plus Thalassemia.
    Journal of pediatric hematology/oncology, 2022, Mar-01, Volume: 44, Issue:2

    Topics: Anemia, Sickle Cell; beta-Thalassemia; Child, Preschool; Humans; Hydroxyurea; Male; Osteonecrosis; T

2022
Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?
    Blood, 2013, Apr-11, Volume: 121, Issue:15

    Topics: Aged; Anemia, Sickle Cell; Antisickling Agents; Erythrocyte Deformability; Female; Humans; Hydroxyur

2013
Severity of Brazilian sickle cell disease patients: severity scores and feasibility of the Bayesian network model use.
    Blood cells, molecules & diseases, 2015, Volume: 54, Issue:4

    Topics: Adult; Age Factors; Aged; Anemia, Sickle Cell; Antisickling Agents; Bayes Theorem; Bilirubin; Brazil

2015
Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis.
    American journal of hematology, 2008, Volume: 83, Issue:10

    Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Brain Infarction; Dura Mater; Follow-Up Studies; He

2008
Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
    American journal of hematology, 2012, Volume: 87, Issue:3

    Topics: Acute Chest Syndrome; Adult; Anemia, Sickle Cell; Antisickling Agents; Biomarkers; Cohort Studies; F

2012